These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 5424427)

  • 1. [Dydrogesterone in the treatment of hypohormonal pregnancy].
    Radulesco JC
    Mars Med; 1970; 107(2):191-6. PubMed ID: 5424427
    [No Abstract]   [Full Text] [Related]  

  • 2. Modulating fertility outcome in assisted reproductive technologies by the use of dydrogesterone.
    Patki A; Pawar VC
    Gynecol Endocrinol; 2007 Oct; 23 Suppl 1():68-72. PubMed ID: 17943542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Progestational properties of dydrogesterone microcrystals and their innocuousness on the somatic sexual differentiation of the rat fetus].
    Marois M; Marois G
    J Gynecol Obstet Biol Reprod (Paris); 1973 Sep; 2(6):645-51. PubMed ID: 4807267
    [No Abstract]   [Full Text] [Related]  

  • 4. The impact of dydrogesterone supplementation on serum cytokine profile in women with threatened abortion.
    Kalinka J; Radwan M
    Am J Reprod Immunol; 2006 Feb; 55(2):115-21. PubMed ID: 16433830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral dydrogesterone treatment during the first trimester of pregnancy: the prevention of miscarriage study (PROMIS). A double-blind, prospectively randomized, placebo-controlled, parallel group trial.
    Walch K; Hefler L; Nagele F
    J Matern Fetal Neonatal Med; 2005 Oct; 18(4):265-9. PubMed ID: 16318978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of dydrogesterone supplementation on hormonal profile and progesterone-induced blocking factor concentrations in women with threatened abortion.
    Kalinka J; Szekeres-Bartho J
    Am J Reprod Immunol; 2005 Apr; 53(4):166-71. PubMed ID: 15760377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of low and high dose oestradiol and dydrogesterone therapy on insulin and lipoprotein metabolism in healthy postmenopausal women.
    Godsland IF; Manassiev NA; Felton CV; Proudler AJ; Crook D; Whitehead MI; Stevenson JC
    Clin Endocrinol (Oxf); 2004 May; 60(5):541-9. PubMed ID: 15104556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclical dydrogesterone in secondary amenorrhea: results of a double-blind, placebo-controlled, randomized study.
    Panay N; Pritsch M; Alt J
    Gynecol Endocrinol; 2007 Nov; 23(11):611-8. PubMed ID: 17891596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is dydrogesterone progesterone?
    Spark MJ
    J Reprod Immunol; 2012 Sep; 95(1-2):101; author reply 102. PubMed ID: 22858348
    [No Abstract]   [Full Text] [Related]  

  • 10. Endometrial safety and bleeding patterns during a 2-year study of 1 or 2 mg 17 beta-estradiol combined with sequential 5-20 mg dydrogesterone.
    Ferenczy A; Gelfand MM; van de Weijer PH; Rioux JE
    Climacteric; 2002 Mar; 5(1):26-35. PubMed ID: 11974556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Action of dydrogesterone in postpubertal menstruation disorders].
    Tabaste JL; Servaud M; Steiner E; Dabir P; Bene B; Pouzet M
    Rev Fr Gynecol Obstet; 1984 Jan; 79(1):19-20, 23-5. PubMed ID: 6531584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors and activation markers of the haemostatic system during hormone therapy: a comparative study of oral estradiol (2 mg)/ dydrogesterone and estradiol (2 mg)/ trimegestone.
    Norris LA; Brosnan J; Bonnar J; Conard J; Kluft C; Hellgren M
    Thromb Haemost; 2008 Aug; 100(2):253-60. PubMed ID: 18690345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hormone replacement therapy with 17 beta-estradiol dydrogesterone: results of a 3-month open-label study].
    Grisar J; Travica S; Metka M; Pietschmann P
    Wien Klin Wochenschr; 1999 Dec; 111(24):1035-43. PubMed ID: 10677891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous combined hormone replacement therapy with 1 mg 17beta-oestradiol and 5 mg dydrogesterone (Femoston-conti): endometrial safety and bleeding profile.
    Quereux C; Pornel B; Bergeron C; Ferenczy A
    Maturitas; 2006 Feb; 53(3):299-305. PubMed ID: 16043317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dydrogesterone (Gynorest and Duphaston).
    Med Lett Drugs Ther; 1969 Apr; 11(7):31-2. PubMed ID: 5781648
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of threatened abortion with dydrogesterone].
    Ehrenskjöld ML; Bondo B; Weile F
    Ugeskr Laeger; 1967 Dec; 129(50):1678-9. PubMed ID: 5889245
    [No Abstract]   [Full Text] [Related]  

  • 17. [The treatment of idiopathic thrombocytopenic purpura in pregnancy].
    Soyka O
    Vnitr Lek; 1966 Nov; 12(11):1118-22. PubMed ID: 6009921
    [No Abstract]   [Full Text] [Related]  

  • 18. [Nonspecific ulcerative colitis in pregnancy].
    Levitan MKh; Smesova RV
    Vrach Delo; 1981 Mar; (3):29-32. PubMed ID: 7293137
    [No Abstract]   [Full Text] [Related]  

  • 19. [Plasma levels of total cholesterol, LDL-cholesterol, and HDL-cholesterol in postmenopausal women during 12 months' oral administration of dydrogesterone or medroxyprogesterone combined with continuous transdermal supplementation of 17beta-estradiol].
    Milewicz T; Kostecka A; Rogatko I; Sztefko K; Kwiatkowska-Panek E; Radowick S; Krzysiek J
    Przegl Lek; 2007; 64(2):65-9. PubMed ID: 17892034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dydrogesterone use during pregnancy: overview of birth defects reported since 1977.
    Queisser-Luft A
    Early Hum Dev; 2009 Jun; 85(6):375-7. PubMed ID: 19193503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.